We present an autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) with extensive amyloid-β (Aβ) deposition in the brain. A 39-year-old Japanese woman presented with memory disturbance and abnormal behavior. The patient had a history of craniotomy with dura matter-graft transplant for a head injury which occurred when she was 19 years old. Magnetic resonance imaging (MRI) showed hyperintensities in the cerebral cortex and striatum on diffusionweighted images, particularly on the dura mater-grafted right side. Her clinical symptoms, including rapidly progressing cognitive impairment, myoclonus, and periodic sharp wave complexes on electroencephalogram, could not be distinguished from typical sporadic CJD cases. The patient died 11 months after symptom onset, and pathological investigations showed extensive spongiform degeneration with prion protein (PrP) deposition without Kuru plaques; these observations were essentially the same as those of typical sporadic CJD cases. Furthermore, Aβ immunohistochemistry showed extensive diffuse staining in the cerebral neocortex, plaque-type deposition, positive staining in the pia mater, and cerebral amyloid angiopathy. Although the MRI findings suggested that the pathological involvement originated from the dura matergrafted right side, the PrP and Aβ depositions showed no apparent regionalization and laterality. Tau-pathology including neurofibrillary tangles was hardly identified. The proteins phosphorylated α-synuclein and phosphorylated transactivation response DNA-binding protein 43 kDa were not detected on immunostaining. Although this report describes only one case, various speculations were made based on detailed clinical and pathological observations in conjunction with previous reports of dCJD. In particular, this report provides significant insight into the characteristics and progression of dCJD pathology and its relationship with Aβ pathology.
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INTRODUCTION
Creutzfeldt-Jakob disease (CJD) is a fatal neurodegenerative disease and can be classified as sporadic (idiopathic), genetic (hereditary), or acquired (infectious). 1 Although the cause of sporadic CJD is still unknown, acquired forms are caused by the transmission of abnormal prion protein (PrP), not only from humans to humans, but also from cattle to humans. [1] [2] [3] Accidental transmission of CJD between humans appears to occur after cadaveric dura mater grafts, corneal transplantations, receipt of human growth hormone or pituitary gonadotropin, contaminated electroencephalogram (EEG) electrodes, and contaminated surgical instruments or apparatus. [1] [2] [3] Since the first report of association between dura mater grafts and CJD was published in 1987, many cases of dura mater graft-associated CJD (dCJD) have been reported. [1] [2] [3] The most probable vehicle of transmission was a single product used in surgery called Lyodura ® (B. Braun Melsungen AG, Melsungen, Germany) produced before May 1987. 3 In comprising over 60% of the total reported global dCJD cases. 5 The widespread use of Lyodura in neurosurgical procedures in Japan is the most probable source of the unusually high number of dCJD cases in this country. 2, 5, 6 Recently, the possibility of human-to-human transmission of cerebral β-amyloidosis has been also suggested in autopsy studies of patients with iatrogenic CJD associated with human growth hormone injections or dura mater grafts. 7, 8 We report the clinicopathological findings of an autopsied case of non-plaque-type dCJD with extensive amyloid-β (Aβ) deposition in the brain.
CLINICAL SUMMARY
A Japanese woman developed memory disturbances and abnormal behaviors at the age of 39 years. For instance, she forgot the orders of customers at her workplace, she repeatedly said the same thing and panicked, she could not exit from a public bus, and she could not wear her work clothes due to executive function disorders. Her cognitive dysfunction rapidly progressed, and she was admitted to the department of neurology 1 month after the onset of symptoms. She had a history of head trauma resulting from a motorcycle accident in 1990 at the age of 19 years. To treat this injury, craniotomy with a dura matter-graft transplant was performed; although the operation record could not be found, Lyodura ® was most likely used in the surgery. Neurological examination revealed poor facial expression, few eye blinks, no apparent dysarthria, slow and simple verbal responses to questions, rigidity in the left extremities, and no Babinski reflex. Mild myoclonus was recognized in the face and upper extremities. The Revised Hasegawa's dementia scale (commonly used in Japan to assess dementia; graded on a scale of 0-30, where < 21 suggests dementia) and Mini-Mental State Examination scores were 13 and 16, respectively. Computed tomography (CT) showed the scar of the craniotomy in the right temporoparietal region (Fig. 1A) . Magnetic resonance imaging (MRI) showed hyperintensities in the cerebral cortex and striatum on T2-weighted images (Fig. 1B) and diffusion-weighted images (DWI) (Fig. 1C) , particularly on the dura mater-grafted right side. Two months after symptom onset, myoclonus became severe in degree, and EEG showed typical periodic sharp wave complexes (PSWCs) without apparent laterality. Three months after symptom onset, the patient reached an akinetic mutism state, and feeding via a nasogastric tube was initiated. Thereafter, the patient's general condition remained stable, and myoclonus gradually disappeared 7 months after symptom onset. MRI showed progression of brain atrophy with ventricular dilation (Fig. 1D) . The patient's general condition suddenly worsened due to aspiration pneumonia, and she died 11 months after symptom onset. Tracheotomy and mechanical ventilation were not performed. Autopsy and PrP gene analyses were performed with the informed consent of the patient's family.
METHODS

Neuropathological examination
The brain was fixed in 20% neutral buffered formalin for 4 weeks. After brain cutting and trimming, tissue blocks were immersed in 95% formic acid for 1 h to inactivate prion infectivity. Eight-micrometer sections sliced using a microtome were mounted, deparaffinized, dehydrated, and stained. For routine neuropathological examinations, sections were subjected to hematoxylin and eosin and Klüver-Barrera stainings, as well as Gallyas-Braak silver staining.
Immunohistochemical analyses of selected sections were performed using a mouse monoclonal antibody against PrP (clone 3F4; diluted 1:100; Dako, Glostrup, Denmark). The 3F4 antibody is specific to human PrP amino acids 109-112. The immunostaining protocol for PrP detection used a hydrolytic autoclaving procedure and the EnVision amplified visualization method as previously described. 9, 10 Immunohistochemistry with a mouse monoclonal antibody against amyloid-β (Aβ) (clone 4G8; diluted 1:2000; Signet, Dedham, MA, USA), a mouse monoclonal antibody against hyperphosphorylated tau (clone AT-8; diluted 1:2000; Innogenetics, Ghent, Belgium), a mouse monoclonal antibody against phosphorylated α-synuclein (clone pSyn#64; diluted 1:3000; Wako Pure Chemical Industries, Osaka, Japan), and a rabbit polyclonal antibody against phosphorylated transactivation response DNA-binding protein 43 kDa (TDP-43) (Cat. No. pTDP-43 pS409/410; diluted 5000; CosmoBio, Tokyo, Japan) was also performed. In these immunostainings, primary antibody binding was detected using the labeled streptavidin-biotin method. Peroxidase-conjugated streptavidin was visualized with 3,3 0 -diaminobenzidine as the final chromogen. Immunostained sections were lightly counterstained with Mayer's hematoxylin.
Genetic and Western blot analyses
The cryopreserved right frontal cerebral cortex, which was snap frozen and stored at −80 C prior to use, was homogenized, and Western blot analysis of protease-resistant PrP (PrP Sc ) was performed using 3F4 antibodies as previously described. 9,10 PrP Sc typing was performed according to the sporadic CJD classification system proposed by Parchi et al.
129 and 219 using restriction fragment length polymorphism analysis, as previously described. 9,10 The patient's DNA was also used for apolipoprotein E (ApoE) genotyping.
PATHOLOGICAL FINDINGS Macroscopic findings
The yellowish transplanted dura mater was recognized after craniotomy at the autopsy, but it was strongly stuck to the skull and hard to remove. The brain weight was reduced to 930 g before fixation due to severe cerebral atrophy ( Fig. 2A) . Coronal sections of the cerebrum showed diffuse atrophy of the cortex and white matter with enlargement of the lateral ventricles (Fig. 2B) . The cerebellum also showed severe atrophy, whereas the brainstem did not.
Microscopic findings
Extensive severe gliosis with hypertrophic astrocytosis and tissue rarefaction of the neuropil were observed in the cerebral neocortex ( Fig. 4A-C) . Florid-type plaques or Kuru-type plaques were not observed. Neuronal loss was extensively observed but to varying degrees in each region. Many inflated neurons were observed, particularly in deeper layers of relatively preserved neocortical regions. The precentral gyrus, including Betz cells, was relatively preserved from neuronal loss. These pathological findings showed no apparent laterality between the right and left cerebral hemispheres. Although the fine vacuoles were indistinct in the cerebral neocortex, typical spongiform changes with fine vacuolization were observed in the hippocampus and subiculum (Fig. 4D) . Although the cerebral white matter showed diffuse myelin pallor and gliosis, the pathology varied across different brain regions (Fig. 3A) . Some circumscribed spongy foci were observed under the crown of the cerebral gyri (Fig. 4E) . The U-fibers, corpus callosum, internal capsule, and parahippocampal gyrus were relatively preserved from myelin pallor. Regarding the subcortical gray matter, the striatum showed similar involvement as the cerebral neocortex (Fig. 4F ). There was no apparent neuron loss within the globus pallidus, but mild spongiform changes and gliosis were observed. The medial thalamus showed severe neuron loss with gliosis, whereas the lateral thalamus was relatively preserved. These pathological findings of the subcortical gray matter also showed no apparent laterality. In the brainstem, the pontine nucleus showed mild neuron loss with gliosis (Fig. 3H) . The substantia nigra and the inferior olivary nucleus were preserved. Pyramidal tract degeneration was not observed. In the cerebellum, the molecular layer showed severe atrophy, and the granule cell layer showed severe neuron loss (Fig. 3I) . The Purkinje cell layer showed mild neuron loss with mild Bergmann gliosis. The cerebellar white matter also showed mild myelin pallor, but the cerebellar dentate nucleus was relatively preserved.
Regarding the anti-PrP immunostaining, diffuse synaptictype PrP deposition was extensively observed in the gray matter, particularly in the cerebral cortex (Fig. 3B, 5A) , striatum, medial thalamus, pontine nucleus, inferior olivary nucleus, cerebellar cortex (Fig. 5B) , and dentate nucleus. PrP deposition showed no apparent laterality between both cerebral hemispheres. Anti-Aβ immunostaining also showed extensive diffuse staining in the cerebral cortex (Fig. 3C , 5C-I); the diffuse Aβ staining tended to be strong and mainly observed in the superficial layer of the cerebral cortex. Plaque-type Aβ deposition (senile plaques; SPs) and positive staining of the pia mater were also extensively observed. Severe cerebral amyloid angiopathy was also extensively observed (Fig. 5J) . Aβ deposition showed no apparent laterality. The dura mater showed no apparent Aβ deposits, whereas the arachnoid granule did (Fig. 5K) . The distribution and density of the SPs were judged as Braak SPs stage C and Consortium to Establish a Registry for Alzheimer's disease (CERAD) SPs stage B.
12,13 The Thal phase of Aβ deposition was judged as 5. Neurofibrillary tangles (NFTs) were hardly identified (Braak NFTs stage I), 12 using Gallyas-Braak silver staining and AT-8 immunostaining (Fig. 5L) . No argyrophilic grains were observed. Lewy bodies and α-synuclein pathology were not observed on antiphosphorylated α-synuclein immunostaining. No apparent positive findings were observed for anti-phosphorylated TDP-43 immunostaining.
RESULTS OF GENETIC ANALYSIS
No mutation in the PrP gene open reading frame was identified. Methionine homozygosity at codon 129 and glutamic acid homozygosity at codon 219, which are the most common polymorphic genotypes of the PrP gene in the Japanese population, 15 were identified. ApoE gene analysis revealed epsilon 3 (e3) homozygosity. 1, [16] [17] [18] In terms of the incubation period, there is no significant difference between the two subtypes. 18 Because the patient in the present case presented with a rapidly progressive clinical course and did not show Kuru plaques, her CJD was considered to belong to the non-plaque-type. Several reports have speculated that Aβ pathology might result from seeding of Aβ aggregation by dura mater grafts. 6, 19, 20 Frontzek et al. investigated amyloid angiopathy and brain parenchymal Aβ plaques in dCJD and speculated that Aβ pathology may occur after long intervals (> 20 years) post dura mater-graft transplant. 19 Hamaguchi et al. reported a significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy in an investigation of Japanese dCJD cases (the present case was not included in their study series); 6 their observations indicated that Aβ deposition in the brain was observed in 13 of 16 patients with dCJD (81.2%). They also indicated that there was a statistically significant correlation between the incubation period and both subpial Aβ deposition and cerebral amyloid angiopathy. 6 Preusser et al. also reported an
RESULTS OF WESTERN BLOT ANALYSIS
Alzheimer-type pathology in a 28-year-old patient with dCJD after dura grafting at the age of 5 years. 20 Although the incidence of dCJD appears to have peaked in the late 1990s and has been declining since, 5, 21 there remains a possibility that cases of dCJD with long incubation periods will manifest in the future, especially in Japan. Therefore, the future onset of dCJD cases may present as a higher occurrence of Aβ pathology. The pathological findings using anti-Aβ immunostaining in the present case suggested direct Aβ infection of the surface of the cerebral cortex. How the infective agent migrates from the site of initial infection into the brain remains a matter of speculation. Initial manifestations and/or EEG findings have been reported to be correlated with the graft site in some cases of dCJD. 1, 9 In addition, initial symptoms of dCJD have been associated with MRI abnormalities of dura mater-graft sites; 22 the present case also showed similar characteristics. The symptoms at onset in patients with dCJD who receive dura mater transplants below the cerebellar tent tend to show cerebellar or brainstem involvement, whereas the patients who receive the transplant above the cerebellar tent tend to show cerebral cortical involvement. 9,23 Sakai et al. statistically investigated the clinical courses in Japanese dCJD cases according to the grafting sites (supratentorial and infratentorial groups) and concluded that PrP shows direct propagation into the brain from contaminated dura mater grafts in the non-plaque-type dCJD cases. 23 When we consider these findings together, Aβ transmission may be driven by a similar mechanism. Although the present case showed extensive Aβ deposition, tau pathology including NFTs was hardly observed. Because the ABC scores for the neuropathologic changes in AD of the present case were A3 (the Thal phase of Aβ deposition was 5), B1 (Braak NFTs stage was 1), and C2 (CERAD SPs stage was B), 24 the combination score was judged as "low." 24 Therefore, the pathologic findings of the present case did not lead to a diagnosis of AD and the cognitive impairment seen in the present case could not be definitively attributed to AD pathology. Although the APOE e4 allele is associated with increased risk of AD including SPs, the present case had e3 allele homozygosity. Our neuropathologic observations of the present case were essentially the same as those of prior reports of sporadic CJD with panencephalopathic pathology reported by our laboratory, 10, 25 except for the extensive Aβ deposition.
Although regionalization or laterality of both neuropathological involvements and PrP depositions were not apparent in the present case, the clinical features and MRI findings suggested that these changes originated from the region around the implanted cadaveric dura mater graft. Aβ deposition with plaques and cerebral amyloid angiopathy were also extensively and symmetrically observed not only in the cerebrum, but also in the cerebellum and the brainstem. Although there was no apparent evidence of particular accentuation of neuropathologic findings or PrP and Aβ accumulation near the dura matergraft sites, we speculate that such neuropathologic involvement must have begun at the right cerebral cortical region contact to the graft and must have progressed extensively due to the long disease duration by the time of the autopsy. Because the pathological findings can only be observed post mortem, it is necessary to investigate the sequential changes of the neurological and MRI findings to speculate on the progression of the neuropathologic lesions.
In conclusion, this report provides significant insight into the characteristics and progression of dCJD pathology and its relationship with Aβ pathology. Given the limited number of autopsied cases of dCJD, however, future work and evaluation of additional cases are necessary in order to clarify the interpretations of the present case study and the pathogenesis of dCJD.
